CEO

Robert Davidson

Rob oversees the sustained growth and diversified revenue strategy for CURE, an innovative drug delivery, and development company committed to improving drug efficacy, safety, and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and Germany, among other markets. The Company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.